DrugPatentWatch Database Preview
Email this page to a colleague
« Back to Dashboard
Qmiiz Odt is a drug marketed by Tersera and is included in one NDA. There is one patent protecting this drug.
This drug has one patent family member in one country.
The generic ingredient in QMIIZ ODT is meloxicam. There are twenty-two drug master file entries for this compound. Forty suppliers are listed for this compound. Additional details are available on the meloxicam profile page.
A generic version of QMIIZ ODT was approved as meloxicam by CIPLA on July 19th, 2006.
|Applicant||Tradename||Generic Name||Dosage||NDA||Approval Date||TE||Type||RLD||RS||Patent No.||Patent Expiration||Product||Substance||Delist Req.||Exclusivity Expiration|
|Tersera||QMIIZ ODT||meloxicam||TABLET, ORALLY DISINTEGRATING;ORAL||211210-001||Oct 19, 2018||DISCN||Yes||No||⤷ Try it Free||⤷ Try it Free||Y||⤷ Try it Free|
|Tersera||QMIIZ ODT||meloxicam||TABLET, ORALLY DISINTEGRATING;ORAL||211210-002||Oct 19, 2018||DISCN||Yes||No||⤷ Try it Free||⤷ Try it Free||Y||⤷ Try it Free|
|>Applicant||>Tradename||>Generic Name||>Dosage||>NDA||>Approval Date||>TE||>Type||>RLD||>RS||>Patent No.||>Patent Expiration||>Product||>Substance||>Delist Req.||>Exclusivity Expiration|